Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -13,73k | 24,57k | Sale to Issuer | 1,79 | 2,02M | -0,68% |
| 2026-05-14 | Ms. Katharine PetersonVP of Finance & Accounting | -99,00 | 190,08 | Sale to Issuer | 1,92 | 3,91k | -2,47% |
| 2026-05-14 | Dr. Erick GamelinChief Development Officer | -404,00 | 775,68 | Sale to Issuer | 1,92 | 11,90k | -3,28% |
| 2026-05-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -184,00 | 353,28 | Sale to Issuer | 1,92 | 25,95k | -0,70% |
| 2026-05-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -490,00 | 940,80 | Sale to Issuer | 1,92 | 310,30k | -0,16% |
| 2026-05-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -1,25k | 2,41k | Sale to Issuer | 1,92 | 1,99M | -0,06% |
| 2026-04-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -558,00 | 993,24 | Sale to Issuer | 1,78 | 25,51k | -2,14% |
| 2026-02-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -14,27k | 21,83k | Sale to Issuer | 1,53 | 1,99M | -0,71% |
| 2026-02-14 | Ms. Katharine PetersonVP of Finance & Accounting | -116,00 | 189,08 | Sale to Issuer | 1,63 | 4,01k | -2,81% |
| 2026-02-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -217,00 | 353,71 | Sale to Issuer | 1,63 | 24,17k | -0,89% |
| 2026-02-14 | Dr. Erick GamelinChief Development Officer | -471,00 | 767,73 | Sale to Issuer | 1,63 | 11,06k | -4,09% |
| 2026-02-14 | Dr. Eric J. DevroeCOO | -723,00 | 1,18k | Sale to Issuer | 1,63 | 68,33k | -1,05% |
| 2026-02-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -1,30k | 2,12k | Sale to Issuer | 1,63 | 1,96M | -0,07% |
| 2026-02-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -579,00 | 943,77 | Sale to Issuer | 1,63 | 309,12k | -0,19% |
| 2026-01-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -659,00 | 1,30k | Sale to Issuer | 1,98 | 23,76k | -2,70% |
| 2026-01-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | 49,00k | 82,12k | Kauf | 1,68 | 1,97M | 2,56% |
| 2026-01-14 | Dr. Adam D. LevyCFO & Principal Financial Officer | 8,83k | 15,00k | Kauf | 1,70 | 13,75k | 179,73% |
| 2026-01-13 | Dr. Eric J. DevroeCOO | 10,00k | 17,22k | Kauf | 1,72 | 66,96k | 17,56% |
| 2025-11-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -19,90k | 45,78k | Sale to Issuer | 2,30 | 1,92M | -1,03% |
| 2025-11-14 | Ms. Katharine PetersonVP of Finance & Accounting | -99,00 | 221,76 | Sale to Issuer | 2,24 | 4,12k | -2,35% |
| 2025-11-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -184,00 | 412,16 | Sale to Issuer | 2,24 | 22,52k | -0,81% |
| 2025-11-14 | Dr. Erick GamelinChief Development Officer | -403,00 | 902,72 | Sale to Issuer | 2,24 | 10,28k | -3,77% |
| 2025-11-14 | Dr. Eric J. DevroeCOO | -613,00 | 1,37k | Sale to Issuer | 2,24 | 56,96k | -1,06% |
| 2025-11-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -59,77k | 133,87k | Sale to Issuer | 2,24 | 1,89M | -3,07% |
| 2025-11-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -490,00 | 1,10k | Sale to Issuer | 2,24 | 308,03k | -0,16% |
| 2025-10-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -558,00 | 1,01k | Sale to Issuer | 1,81 | 20,18k | -2,69% |
| 2025-10-01 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -284,00 | 514,04 | Sale to Issuer | 1,81 | 20,73k | -1,35% |
| 2025-08-21 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -19,91k | 26,27k | Sale to Issuer | 1,32 | 1,82M | -1,08% |
| 2025-08-14 | Ms. Katharine PetersonVP of Finance & Accounting | -99,00 | 137,61 | Sale to Issuer | 1,39 | 4,22k | -2,29% |
| 2025-08-14 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -184,00 | 255,76 | Sale to Issuer | 1,39 | 20,05k | -0,91% |
| 2025-08-14 | Dr. Erick GamelinChief Development Officer | -403,00 | 560,17 | Sale to Issuer | 1,39 | 9,43k | -4,10% |
| 2025-08-14 | Dr. Eric J. DevroeCOO | -613,00 | 852,07 | Sale to Issuer | 1,39 | 55,49k | -1,09% |
| 2025-08-14 | Dr. Peter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer | -59,77k | 83,07k | Sale to Issuer | 1,39 | 1,80M | -3,21% |
| 2025-08-14 | Ms. Kristina MassonCo-Founder, Exec. VP of Business Operations, Site Head, Treasurer & Director | -490,00 | 681,10 | Sale to Issuer | 1,39 | 306,85k | -0,16% |
| 2025-08-01 | Dr. Adam D. LevyCFO & Principal Financial Officer | -1,16k | 1,47k | Sale to Issuer | 1,26 | 4,91k | -19,15% |
| 2025-07-17 | Ms. Mary-Alice MillerChief Legal Officer & Corporate Secretary | -558,00 | 736,56 | Sale to Issuer | 1,32 | 20,34k | -2,67% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
